External Source

Positive Interim Data In Gene Therapy Trial For Gm1 Gangliosidosis

2022 3:29
Synopsis
Mark Forman, MD, PhD, Chief Medical Officer at Passage Bio, discusses long-term clinical and biomarker data from Cohort 1 in ...

You Might Also Like

Interim Data from Gene Therapy for GM1 Gangliosidosis Shows Dramatic Improvement 6:27
Interim Data From Gene Therapy For Gm1 Gangliosidosis Shows ...
2022
Updated Gene Therapy Trial for GM1 Gangliosidosis 5:26
Updated Gene Therapy Trial For Gm1 Gangliosidosis
2023
Gene Therapy for GM1 Gangliosidosis 2:48
Gene Therapy For Gm1 Gangliosidosis
2021
GM1 Gangliosidosis Explained 2:21
Gm1 Gangliosidosis Explained
2023
Using Gene Therapy to Treat GM1 Gangliosidosis 2:11
Using Gene Therapy To Treat Gm1 Gangliosidosis
2022
Axovant Intravenous Gene Therapy for GM1 Gangliosidosis 2020 2:52
Axovant Intravenous Gene Therapy For Gm1 Gangliosidosis 2020
2020
LYS-GM101 AAV gene therapy for GM1 gangliosidosis 6:19
Lys-gm101 Aav Gene Therapy For Gm1 Gangliosidosis
2022
Gene Therapy UpdateGM1 Gangliosidosis & Krabbe - PassageBio 15:31
Gene Therapy updategm1 Gangliosidosis & Krabbe - Passagebio
2022
NTSAD Virtual Family Conference 2020: GM1 Gangliosidosis Breakout | Passage Bio 25:55
Ntsad Virtual Family Conference 2020: Gm1 Gangliosidosis Bre...
2020
NTSAD GM1 Breakout | Passage Bio 24:23
Ntsad Gm1 Breakout | Passage Bio
2021
Clinical Trials Are Coming for GM1 Gangliosidosis 0:19
Clinical Trials Are Coming For Gm1 Gangliosidosis
2019
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.